Grantham, Mayo, Van Otterloo & Co (GMO)’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $915M | Buy |
8,910,945
+428,392
| +5% | +$48.4M | 2.34% | 13 |
|
|
2025
Q4 | $1.06B | Buy |
8,482,553
+306,069
| +4% | +$39M | 2.72% | 11 |
|
|
2025
Q3 | $1.1B | Buy |
8,176,484
+361,946
| +5% | +$47.5M | 3.09% | 8 |
|
|
2025
Q2 | $1.06B | Sell |
7,814,538
-293,045
| -4% | -$38.6M | 3.2% | 6 |
|
|
2025
Q1 | $1.08B | Buy |
8,107,583
+210,644
| +3% | +$26.8M | 3.39% | 7 |
|
|
2024
Q4 | $893M | Buy |
7,896,939
+787,251
| +11% | +$91M | 2.91% | 9 |
|
|
2024
Q3 | $811M | Buy |
7,109,688
+1,317,528
| +23% | +$145M | 2.54% | 11 |
|
|
2024
Q2 | $602M | Buy |
5,792,160
+384,152
| +7% | +$40.7M | 2.03% | 16 |
|
|
2024
Q1 | $615M | Buy |
5,408,008
+1,032,651
| +24% | +$118M | 2.23% | 15 |
|
|
2023
Q4 | $482M | Buy |
4,375,357
+710,501
| +19% | +$71M | 2.13% | 13 |
|
|
2023
Q3 | $355M | Buy |
3,664,856
+801,191
| +28% | +$84.1M | 1.68% | 16 |
|
|
2023
Q2 | $312M | Buy |
2,863,665
+1,215,172
| +74% | +$130M | 1.45% | 19 |
|
|
2023
Q1 | $167M | Buy |
1,648,493
+13,059
| +0.8% | +$1.38M | 0.85% | 29 |
|
|
2022
Q4 | $180M | Sell |
1,635,434
-15,800
| -1% | -$1.64M | 0.96% | 29 |
|
|
2022
Q3 | $160M | Buy |
1,651,234
+43,860
| +3% | +$4.67M | 0.92% | 30 |
|
|
2022
Q2 | $175M | Sell |
1,607,374
-40,129
| -2% | -$4.56M | 0.95% | 27 |
|
|
2022
Q1 | $195M | Sell |
1,647,503
-41,277
| -2% | -$5.12M | 0.94% | 27 |
|
|
2021
Q4 | $238M | Sell |
1,688,780
-67,118
| -4% | -$8.59M | 1.14% | 23 |
|
|
2021
Q3 | $207M | Buy |
1,755,898
+24,686
| +1% | +$3.03M | 1.03% | 25 |
|
|
2021
Q2 | $201M | Buy |
1,731,212
+6,799
| +0.4% | +$793K | 1% | 25 |
|
|
2021
Q1 | $207M | Sell |
1,724,413
-53,582
| -3% | -$6.35M | 1.13% | 26 |
|
|
2020
Q4 | $195M | Sell |
1,777,995
-132,242
| -7% | -$14.4M | 1.2% | 24 |
|
|
2020
Q3 | $208M | Buy |
1,910,237
+710,770
| +59% | +$72.1M | 1.48% | 23 |
|
|
2020
Q2 | $110M | Sell |
1,199,467
-252,951
| -17% | -$22.9M | 0.81% | 31 |
|
|
2020
Q1 | $115M | Sell |
1,452,418
-353,745
| -20% | -$29.5M | 0.96% | 30 |
|
|
2019
Q4 | $157M | Buy |
1,806,163
+5,195
| +0.3% | +$435K | 1.05% | 25 |
|
|
2019
Q3 | $151M | Buy |
1,800,968
+52,749
| +3% | +$4.48M | 1.05% | 29 |
|
|
2019
Q2 | $147M | Sell |
1,748,219
-89,609
| -5% | -$7.05M | 1.03% | 27 |
|
|
2019
Q1 | $147M | Sell |
1,837,828
-181,881
| -9% | -$13.5M | 1.06% | 28 |
|
|
2018
Q4 | $146M | Sell |
2,019,709
-255,139
| -11% | -$17.9M | 1.17% | 26 |
|
|
2018
Q3 | $167M | Sell |
2,274,848
-283,391
| -11% | -$18.6M | 1.13% | 27 |
|
|
2018
Q2 | $156M | Sell |
2,558,239
-826,002
| -24% | -$50.1M | 1.11% | 27 |
|
|
2018
Q1 | $203M | Sell |
3,384,241
-1,436,126
| -30% | -$86.5M | 1.24% | 25 |
|
|
2017
Q4 | $275M | Sell |
4,820,367
-33,200
| -0.7% | -$1.84M | 1.62% | 16 |
|
|
2017
Q3 | $259M | Sell |
4,853,567
-398,392
| -8% | -$20M | 1.51% | 19 |
|
|
2017
Q2 | $255M | Buy |
5,251,959
+243,161
| +5% | +$11M | 1.41% | 19 |
|
|
2017
Q1 | $222M | Buy |
5,008,798
+523,854
| +12% | +$22.6M | 1.25% | 19 |
|
|
2016
Q4 | $172M | Sell |
4,484,944
-25,404
| -0.6% | -$1.01M | 0.93% | 27 |
|
|
2016
Q3 | $191M | Buy |
4,510,348
+165,114
| +4% | +$7.07M | 0.9% | 22 |
|
|
2016
Q2 | $171M | Buy |
4,345,234
+632,054
| +17% | +$25.2M | 0.7% | 35 |
|
|
2016
Q1 | $155M | Sell |
3,713,180
-1,940,133
| -34% | -$76.9M | 0.58% | 41 |
|
|
2015
Q4 | $254M | Sell |
5,653,313
-815,905
| -13% | -$36M | 0.91% | 27 |
|
|
2015
Q3 | $260M | Sell |
6,469,218
-3,030,001
| -32% | -$143M | 0.9% | 25 |
|
|
2015
Q2 | $466M | Sell |
9,499,219
-1,228,600
| -11% | -$59M | 1.5% | 18 |
|
|
2015
Q1 | $497M | Buy |
10,727,819
+1,617,597
| +18% | +$74.3M | 1.48% | 18 |
|
|
2014
Q4 | $410M | Sell |
9,110,222
-1,045,381
| -10% | -$45.5M | 1.1% | 22 |
|
|
2014
Q3 | $422M | Sell |
10,155,603
-1,800,905
| -15% | -$76.2M | 1.12% | 23 |
|
|
2014
Q2 | $489M | Sell |
11,956,508
-4,404,313
| -27% | -$173M | 1.33% | 21 |
|
|
2014
Q1 | $630M | Buy |
16,360,821
+206,170
| +1% | +$7.95M | 1.64% | 17 |
|
|
2013
Q4 | $619M | Buy |
16,154,651
+124,422
| +0.8% | +$4.59M | 1.5% | 20 |
|
|
2013
Q3 | $532M | Sell |
16,030,229
-1,556,600
| -9% | -$54.6M | 1.4% | 20 |
|
|
2013
Q2 | $613M | Buy |
+17,586,829
| New | +$645M | 1.6% | 18 |
|
Other funds holding ABT
VCM
VPM
Grantham, Mayo, Van Otterloo & Co (GMO)'s ABT Position: Q1 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) increased its Abbott (ABT) stake by 5.1% in Q1 2026, buying an estimated $48.4M and bringing the position to 8,910,945 shares worth $915M. The position accounts for 2.34% of the portfolio, ranked #13.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ABT in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.1B in Q3 2025. 3,083 funds tracked by Wall St. Rank hold ABT as of Q1 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 8,910,945 shares of Abbott worth $915M as of Q1 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) bought 428,392 Abbott shares in Q1 2026, an estimated $48.4M.
- Abbott made up 2.34% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #13 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Abbott in Q2 2013 and has held it in 52 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Abbott position peaked at $1.1B in Q3 2025.
- 3,083 funds tracked by Wall St. Rank held Abbott as of Q1 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.